Tecan Group Ltd.
TECN
ISIN CH0012100191 / Valor 1210019
Tecan Group Ltd.
UMushroom community rating:
About company
Tecan Group Ltd. is a Swiss company specializing in laboratory instruments and solutions for the life sciences and healthcare sectors. The company provides a range of products and services designed to enhance the precision, reproducibility, and compliance of laboratory processes and medical procedures. Tecan's offerings include automated laboratory instruments, software solutions, and comprehensive services that support customers from the initial stages of innovation through to project implementation and ongoing operations. By focusing on scalable and reliable outcomes, Tecan plays a crucial role in advancing research and development in various scientific fields, contributing to significant advancements in healthcare and life sciences.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (07.10.2025):
Tecan Group Ltd. reported solid first-half 2023 results despite ongoing uncertainties and a challenging market environment.
Strong First-Half Performance
Tecan Group Ltd. achieved solid results in the first half of 2023, effectively navigating a volatile market and prevailing uncertainties.
Team Resilience and Adaptability
The company's teams demonstrated remarkable resilience and adaptability, enabling steady progress on strategic initiatives.
Progress on Strategic Initiatives
Tecan continued to advance its strategic initiatives, ensuring consistent growth and development despite market headwinds.
Positive Outlook Amid Challenges
While encountering headwinds in certain markets, Tecan Group Ltd. remains cautiously optimistic about the remainder of the year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2099 M
Market cap (USD)
31,146
Daily traded volume (Shares)
206.6 / 203.4
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Anna Trillini
Patrik Schmocker
EQUITIES OF THE SAME SECTOR
